Small-Joint Reconstructive Implants | Market Insights | Europe (Supplemental) | 2024
The European reconstructive small-joint market has largely recovered from the negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the near term; going forward, growth will be driven by high growth in certain subsegments, such as those for shoulder and total ankle arthroplasty. Adoption of small-joint reconstructive implants is rising due to favorable clinical results, a favorable reimbursement environment in Europe, and an expanding pool of trained surgeons, while high product ASPs, supported by ongoing product innovation and comparatively low pricing pressure in this underpenetrated market, will further contribute to strong revenue expansion.
This Medtech 360 Report provides high-level market metrics for reconstructive small-joint in Europe, including country-level data for major countries and aggregate data for the rest of Europe from 2019 through 2032.
